NCT02219971View on ClinicalTrials.gov

Phase I Study of Kukoamine B Mesilate in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

May 6, 2015

Study Completion Date

May 6, 2015

Conditions
Healthy
Interventions
DRUG

Kukoamine B Mesilate

Kukoamine B Mesilate or placebo single-dose and intravenous(IV) drip for 1 hour in healthy volunteers.

Trial Locations (1)

Unknown

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
collaborator

Southwest Hospital, China

OTHER

lead

Tianjin Chasesun Pharmaceutical Co., LTD

INDUSTRY

NCT02219971 - Phase I Study of Kukoamine B Mesilate in Healthy Volunteers | Biotech Hunter | Biotech Hunter